ID   KSR1_HUMAN              Reviewed;         921 AA.
AC   Q8IVT5; Q13476;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   02-NOV-2010, entry version 76.
DE   RecName: Full=Kinase suppressor of Ras 1;
GN   Name=KSR1; Synonyms=KSR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 241-897 (ISOFORM 2).
RX   MEDLINE=96107327; PubMed=8521512; DOI=10.1016/0092-8674(95)90204-X;
RA   Therrien M., Chang H.C., Solomon N.M., Karim F.D., Wassarman D.A.,
RA   Rubin G.M.;
RT   "KSR, a novel protein kinase required for RAS signal transduction.";
RL   Cell 83:879-888(1995).
RN   [4]
RP   REVIEW.
RX   PubMed=12007434; DOI=10.1016/S0960-9822(02)00831-X;
RA   Roy F., Therrien M.;
RT   "MAP kinase module: the Ksr connection.";
RL   Curr. Biol. 12:R325-R327(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-268 AND SER-309, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-268; THR-272 AND
RP   SER-332, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-268; THR-272; SER-332;
RP   SER-404 AND SER-567, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309 AND SER-404, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-404, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-225; ALA-357 AND HIS-661.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Location-regulated scaffolding protein connecting MEK to
CC       RAF. Promotes MEK and RAF phosphorylation and activity through
CC       assembly of an activated signaling complex. By itself, it has no
CC       demonstrated kinase activity.
CC   -!- SUBUNIT: Interacts with HSPCA/HSP90, YWHAB/14-3-3, CDC37,
CC       MAP2K/MEK, MARK3, PPP2R1A and PPP2CA. Also interacts with RAF and
CC       MAPK/ERK, in a Ras-dependent manner (By similarity). The binding
CC       of 14-3-3 proteins to phosphorylated KSR prevents the membrane
CC       localization.
CC   -!- INTERACTION:
CC       Q7Z569:BRAP; NbExp=1; IntAct=EBI-486984, EBI-349900;
CC       Q86Y07:VRK2; NbExp=2; IntAct=EBI-486984, EBI-1207615;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Membrane;
CC       Peripheral membrane protein (By similarity). Note=In unstimulated
CC       cells, where the phosphorylated form is bound to a 14-3-3 protein,
CC       sequestration in the cytoplasm occurs. Following growth factor
CC       treatment, the protein is free for membrane translocation, and it
CC       moves from the cytoplasm to the cell periphery (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IVT5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IVT5-2; Sequence=VSP_012230, VSP_012231;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q8IVT5-3; Sequence=VSP_012229;
CC         Note=No experimental confirmation available;
CC   -!- PTM: Phosphorylated on Ser-309 and, to a higher extent, on Ser-404
CC       by MARK3. Dephosphorylated on Ser-404 by PPP2CA. In resting cells,
CC       phosphorylated KSR1 is cytoplasmic and in stimulated cells,
CC       dephosphorylated KSR1 is membrane-associated (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC069366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC015688; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC042106; AAH42106.1; -; mRNA.
DR   EMBL; U43586; AAC50354.1; -; mRNA.
DR   IPI; IPI00013384; -.
DR   IPI; IPI00217124; -.
DR   IPI; IPI00651657; -.
DR   RefSeq; NP_055053.1; -.
DR   UniGene; Hs.133534; -.
DR   ProteinModelPortal; Q8IVT5; -.
DR   SMR; Q8IVT5; 343-390, 588-878.
DR   IntAct; Q8IVT5; 11.
DR   STRING; Q8IVT5; -.
DR   PhosphoSite; Q8IVT5; -.
DR   PRIDE; Q8IVT5; -.
DR   Ensembl; ENST00000268763; ENSP00000268763; ENSG00000141068.
DR   GeneID; 8844; -.
DR   KEGG; hsa:8844; -.
DR   CTD; 8844; -.
DR   GeneCards; GC17P025799; -.
DR   H-InvDB; HIX0025516; -.
DR   H-InvDB; HIX0029273; -.
DR   H-InvDB; HIX0194754; -.
DR   H-InvDB; HIX0202633; -.
DR   HGNC; HGNC:6465; KSR1.
DR   HPA; CAB009623; -.
DR   HPA; HPA011215; -.
DR   MIM; 601132; gene.
DR   PharmGKB; PA134901167; -.
DR   eggNOG; prNOG06271; -.
DR   HOGENOM; HBG714131; -.
DR   HOVERGEN; HBG052293; -.
DR   InParanoid; Q8IVT5; -.
DR   Pathway_Interaction_DB; ceramidepathway; Ceramide signaling pathway.
DR   NextBio; 33204; -.
DR   ArrayExpress; Q8IVT5; -.
DR   Bgee; Q8IVT5; -.
DR   CleanEx; HS_KSR1; -.
DR   Genevestigator; Q8IVT5; -.
DR   GermOnline; ENSG00000141068; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; NAS:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; NAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00109; C1; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Zinc; Zinc-finger.
FT   CHAIN         1    921       Kinase suppressor of Ras 1.
FT                                /FTId=PRO_0000086229.
FT   DOMAIN      611    881       Protein kinase.
FT   ZN_FING     345    389       Phorbol-ester/DAG-type.
FT   COMPBIAS     17     21       Poly-Gly.
FT   COMPBIAS    287    290       Poly-Pro.
FT   METAL       346    346       Zinc 1 (By similarity).
FT   METAL       358    358       Zinc 2 (By similarity).
FT   METAL       361    361       Zinc 2 (By similarity).
FT   METAL       371    371       Zinc 1 (By similarity).
FT   METAL       374    374       Zinc 1 (By similarity).
FT   METAL       379    379       Zinc 2 (By similarity).
FT   METAL       382    382       Zinc 2 (By similarity).
FT   METAL       389    389       Zinc 1 (By similarity).
FT   MOD_RES     268    268       Phosphothreonine.
FT   MOD_RES     272    272       Phosphothreonine.
FT   MOD_RES     309    309       Phosphoserine.
FT   MOD_RES     332    332       Phosphoserine.
FT   MOD_RES     404    404       Phosphoserine.
FT   MOD_RES     567    567       Phosphoserine.
FT   VAR_SEQ       1    135       Missing (in isoform 3).
FT                                /FTId=VSP_012229.
FT   VAR_SEQ     502    524       VPSAGHCWKCLLIAESLKENAFN -> D (in isoform
FT                                2).
FT                                /FTId=VSP_012230.
FT   VAR_SEQ     897    921       INSSKVVPRFERFGLGVLESSNPKM -> L (in
FT                                isoform 2).
FT                                /FTId=VSP_012231.
FT   VARIANT     225    225       S -> P.
FT                                /FTId=VAR_040658.
FT   VARIANT     357    357       V -> A.
FT                                /FTId=VAR_046048.
FT   VARIANT     661    661       Q -> H.
FT                                /FTId=VAR_046049.
FT   CONFLICT    241    263       FSEGLSDTCIPLHASGRLTPRAL -> EFRHTSALTQHTAH
FT                                TQHTSAHTQ (in Ref. 3).
SQ   SEQUENCE   921 AA;  102032 MW;  FBF2E4976215C313 CRC64;
     MDRAALRAAA MGEKKEGGGG GDAAEGGAGA AASRALQQCG QLQKLIDISI GSLRGLRTKC
     AVSNDLTQQE IRTLEAKLVR YICKQRQCKL SVAPGERTPE LNSYPRFSDW LYTFNVRPEV
     VQEIPRDLTL DALLEMNEAK VKETLRRCGA SGDECGRLQY ALTCLRKVTG LGGEHKEDSS
     WSSLDARRES GSGPSTDTLS AASLPWPPGS SQLGRAGNSA QGPRSISVSA LPASDSPTPS
     FSEGLSDTCI PLHASGRLTP RALHSFITPP TTPQLRRHTK LKPPRTPPPP SRKVFQLLPS
     FPTLTRSKSH ESQLGNRIDD VSSMRFDLSH GSPQMVRRDI GLSVTHRFST KSWLSQVCHV
     CQKSMIFGVK CKHCRLKCHN KCTKEAPACR ISFLPLTRLR RTESVPSDIN NPVDRAAEPH
     FGTLPKALTK KEHPPAMNHL DSSSNPSSTT SSTPSSPAPF PTSSNPSSAT TPPNPSPGQR
     DSRFNFPAAY FIHHRQQFIF PVPSAGHCWK CLLIAESLKE NAFNISAFAH AAPLPEAADG
     TRLDDQPKAD VLEAHEAEAE EPEAGKSEAE DDEDEVDDLP SSRRPWRGPI SRKASQTSVY
     LQEWDIPFEQ VELGEPIGQG RWGRVHRGRW HGEVAIRLLE MDGHNQDHLK LFKKEVMNYR
     QTRHENVVLF MGACMNPPHL AIITSFCKGR TLHSFVRDPK TSLDINKTRQ IAQEIIKGMG
     YLHAKGIVHK DLKSKNVFYD NGKVVITDFG LFGISGVVRE GRRENQLKLS HDWLCYLAPE
     IVREMTPGKD EDQLPFSKAA DVYAFGTVWY ELQARDWPLK NQAAEASIWQ IGSGEGMKRV
     LTSVSLGKEV SEILSACWAF DLQERPSFSL LMDMLEKLPK LNRRLSHPGH FWKSAEINSS
     KVVPRFERFG LGVLESSNPK M
//
